Advertisement
UK markets closed

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • CRUDE OIL

    82.56
    -0.25 (-0.30%)
     

  • GOLD FUTURES

    2,340.70
    +2.30 (+0.10%)
     

  • DOW

    38,005.62
    -455.30 (-1.18%)
     

  • Bitcoin GBP

    51,655.91
    -211.73 (-0.41%)
     

  • CMC Crypto 200

    1,392.17
    +9.59 (+0.69%)
     

  • NASDAQ Composite

    15,542.56
    -170.19 (-1.08%)
     

  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

BUZZ-Novo Nordisk up as rival drug faces delay in the U.S -analysts

Reuters - UK Focus

** Insulin maker Novo Nordisk (Other OTC: NONOF - news) up 3.5%, top performer on Stoxx 600 Healthcare index

** Novo lifted as rival AstraZeneca (NYSE: AZN - news) 's diabetes drug combination was rebuffed by U.S (Other OTC: UBGXF - news) . health regulators on Friday -analysts

** Novo's rally on Friday follows recent underperformance v sector (down c3% over last 4 weeks v

(RM (LSE: RM.L - news) :teis.jensen.thomsonreuters.com@reuters.net)